Skip to main content

Brian J. Druker - "Imatinib as a Paradigm of Targeted Cancer Therapies"

No Ratings

2023 AADOCR/CADR Annual Meeting

The 2023 AADOCR/CADR Annual Meeting & Exhibition provided dental, oral, and craniofacial health scientists with the opportunity to present, discuss, and critique their latest and most cutting-edge research at a 100% in-person gathering in Portland, Oregon. The meeting was attended by 2,054 individuals from 39 countries.     

The recordings in this library from the meeting are a selection of the science that was presented at the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.

This session can be purchased as part of the full meeting recordings within the product bundles

The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at

Brian J. Druker
Director, OHSU Knight Cancer Institute

Distinguished Lecture Series

Learning Objectives
  • Understand the path of targeted drug development from target identification through clinical trials and understand potential mechanisms of resistance to targeted therapies.
Presentation Date
Friday, March 17, 2023

CE Credits
1 Hours
Not eligible for individual purchase must purchase as part of a meeting bundle.